The store will not work correctly when cookies are disabled.
4-(4-tert-butylphenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one
ID: ALA3976673
PubChem CID: 18385637
Max Phase: Preclinical
Molecular Formula: C23H26O4S
Molecular Weight: 398.52
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(C)OC(c2ccc(S(C)(=O)=O)cc2)=C(c2ccc(C(C)(C)C)cc2)C1=O
Standard InChI: InChI=1S/C23H26O4S/c1-22(2,3)17-11-7-15(8-12-17)19-20(27-23(4,5)21(19)24)16-9-13-18(14-10-16)28(6,25)26/h7-14H,1-6H3
Standard InChI Key: YEOFGRCGUIPWRA-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
16.5003 -1.0042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2877 -1.8042 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.0868 -1.5883 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0462 -6.4501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6378 -5.7376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2249 -6.4475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9735 -5.2537 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3097 -5.2545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0540 -4.4675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2299 -4.4707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0937 -5.5115 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7462 -3.8086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0828 -3.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5980 -2.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7767 -2.4742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4424 -3.2332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9293 -3.8965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5342 -3.7999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3559 -3.8859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8393 -3.2184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5023 -2.4644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6772 -2.3820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1973 -3.0505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4699 -1.8959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9851 -1.7953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8059 -1.8788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6470 -1.0428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3920 -1.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 1 0
6 5 1 0
7 5 1 0
5 8 1 0
8 9 1 0
9 10 2 0
10 7 1 0
8 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
9 18 1 0
15 2 1 0
2 24 1 0
21 25 1 0
25 26 1 0
25 27 1 0
25 28 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 398.52 | Molecular Weight (Monoisotopic): 398.1552 | AlogP: 4.63 | #Rotatable Bonds: 3 |
Polar Surface Area: 60.44 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.58 | CX LogD: 4.58 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.76 | Np Likeness Score: -0.19 |
References
1. (2002) 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors, |